The tuberculosis vaccine candidate bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Rao, Martin ^a   Vogelzang, Alexis ^a   Kaiser, Peggy ^a   Schuerer, Stefanie ^a   Kaufmann, Stefan H E ^a   Gengenbacher, Martin ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS CALMETTE GUERIN DELTA UREC::HLY INTERLEUKIN 18 VACCINE; BACILLUS CALMETTE GUERIN DELTA UREC::HLY INTERLEUKIN 7 VACCINE; BACILLUS CALMETTE GUERIN DELTA UREC::HLY VACCINE; BACTERIAL VACCINE; BCG VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD40 LIGAND; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-18; INTERLEUKIN-7; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SPLEEN; TH1 CELLS; TUBERCULOSIS; VACCINATION;

EID: 84893186619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078966     Document Type: Article

References (55)

1. Global Tuberculosis Report (2012) Geneva: World Health Organization. 282 p.
2. Kaufmann SH, McMichael AJ (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nature medicine 11: S33-44. (Pubitemid 40562302)
3. Kwan CK, Ernst JD (2011) HIV and tuberculosis: a deadly human syndemic. Clinical microbiology reviews 24: 351-376.
4. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al. (2010) HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. American journal of respiratory and critical care medicine 181: 80-86.
5. Kaufmann SH (2007) The contribution of immunology to the rational design of novel antibacterial vaccines. Nature reviews Microbiology 5: 491-504.
6. Andersen P, Doherty TM (2005) The success and failure of BCG - implications for a novel tuberculosis vaccine. Nature reviews Microbiology 3: 656-662. (Pubitemid 41052152)
7. Kaufmann SHE (2011) Fact and fiction in tuberculosis vaccine research: 10 years later. The Lancet Infectious Diseases 11: 633-640.
8. Reece ST, Kaufmann SH (2008) Rational design of vaccines against tuberculosis directed by basic immunology. International journal of medical microbiology : IJMM 298: 143-150. (Pubitemid 350216548)
9. Kaufmann SH (2012) Tuberculosis vaccine development: strength lies in tenacity. Trends in immunology 33: 373-379.
10. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, et al. (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. The Journal of clinical investigation 115: 2472-2479. (Pubitemid 41266209)
11. Grode L, Ganoza CA, Brohm C, Weiner J, 3rd, Eisele B, et al. (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine.
12. Kaufmann SH (2010) Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 33: 567-577.
13. Schneider BE, Korbel D, Hagens K, Koch M, Raupach B, et al. (2010) A role for IL-18 in protective immunity against Mycobacterium tuberculosis. European journal of immunology 40: 396-405.
14. Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, et al. (2006) Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS medicine 3: e277.
15. Maeurer MJ, Trinder P, Hommel G, Walter W, Freitag K, et al. (2000) Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice. Infection and Immunity 68: 2962-2970. (Pubitemid 30253878)
16. Singh V, Gowthaman U, Jain S, Parihar P, Banskar S, et al. (2010) Coadministration of interleukins 7 and 15 with bacille Calmette-Guerin mounts enduring T cell memory response against Mycobacterium tuberculosis. The Journal of infectious diseases 202: 480-489.
17. Appasamy PM (1993) Interleukin-7: biology and potential clinical applications. Cancer investigation 11: 487-499.
18. Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. Journal of Leukocyte Biology 73: 213-224. (Pubitemid 36158296)
19. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annual review of immunology 31: 475-527.
20. Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, et al. (1999) Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infection and Immunity 67: 2585-2589. (Pubitemid 29200522)
21. Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, et al. (2000) Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. American journal of respiratory and critical care medicine 161: 1786-1789. (Pubitemid 30418108)
22. Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C (2002) Mycobacterium bovis BCG Producing Interleukin-18 Increases Antigen-Specific Gamma Interferon Production in Mice. Infection and Immunity 70: 6549-6557. (Pubitemid 35387880)
23. O'Donnell MA, Aldovini A, Duda RB, Yang H, Szilvasi A, et al. (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infection and Immunity 62: 2508-2514. (Pubitemid 24157083)
24. Murray PJ, Aldovini A, Young RA (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proceedings of the National Academy of Sciences of the United States of America 93: 934-939.
25. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, et al. (1998) Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proceedings of the National Academy of Sciences of the United States of America 95: 5299-5304.
26. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, et al. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460. (Pubitemid 21896614)
27. Malaga W, Perez E, Guilhot C (2003) Production of unmarked mutations in mycobacteria using site-specific recombination. FEMS microbiology letters 219: 261-268. (Pubitemid 36302607)
28. Rovai LE, Herschman HR, Smith JB (1998) The murine neutrophil- chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. Journal of Leukocyte Biology 64: 494-502. (Pubitemid 28455395)
29. Roberts AW (2005) G-CSF: a key regulator of neutrophil production, but that's not all! Growth factors 23: 33-41.
30. Sehgal PB, May LT, Tamm I, Vilcek J (1987) Human beta 2 interferon and Bcell differentiation factor BSF-2 are identical. Science 235: 731-732.
31. Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, et al. (1988) B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. The Journal of experimental medicine 167: 1253-1258.
32. Dinarello CA, Cannon JG, Mancilla J, Bishai I, Lees J, et al. (1991) Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain research 562: 199-206.
33. Malek TR (2008) The biology of interleukin-2. Annual review of immunology 26: 453-479.
34. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671. (Pubitemid 20356243)
35. Behr MA, Small PM (1999) A historical and molecular phylogeny of BCG strains. Vaccine 17: 915-922. (Pubitemid 29074746)
36. Lalvani A, Sridhar S (2010) BCG vaccination: 90 years on and still so much to learn. Thorax 65: 1036-1038.
37. Norton BL, Holland DP (2012) Current management options for latent tuberculosis: a review. Infection and drug resistance 5: 163-173.
38. Kaufmann SH, Gengenbacher M (2012) Recombinant live vaccine candidates against tuberculosis. Current opinion in biotechnology 23: 900-907.
39. Arama C, Waseem S, Fernandez C, Assefaw-Redda Y, You L, et al. (2012) A recombinant Bacille Calmette-Guerin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice. Vaccine 30: 5578-5584.
40. Joseph J, Fernandez-Lloris R, Pezzat E, Saubi N, Cardona PJ, et al. (2010) Molecular characterization of heterologous HIV-1gp120 gene expression disruption in Mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors. Journal of biomedicine & biotechnology 2010: 357370.
41. Fennelly GJ, Flynn JL, ter Meulen V, Liebert UG, Bloom BR (1995) Recombinant bacille Calmette-Guerin priming against measles. The Journal of infectious diseases 172: 698-705.
42. Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, et al. (1994) Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. The Journal of experimental medicine 180: 2277-2286.
43. Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, et al. (1993) Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. The Journal of experimental medicine 178: 197-209. (Pubitemid 23173255)
44. Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nature reviews Immunology 7: 144-154. (Pubitemid 46178275)
45. Goodwin RG, Lupton S, Schmierer A, Hjerrild KJ, Jerzy R, et al. (1989) Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proceedings of the National Academy of Sciences of the United States of America 86: 302-306. (Pubitemid 19036374)
46. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544. (Pubitemid 28319235)
47. Kipnis A, Basaraba RJ, Orme IM, Cooper AM (2003) Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 109: 547-551. (Pubitemid 36930170)
48. Redford PS, Boonstra A, Read S, Pitt J, Graham C, et al. (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. European journal of immunology 40: 2200-2210.
49. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G (2010) CCL5 participates in early protection against Mycobacterium tuberculosis. Journal of Leukocyte Biology 87: 1153-1165.
50. Shin H, Iwasaki A (2012) A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491: 463-467.
51. Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, et al. (2005) Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106: 1843-1850. (Pubitemid 41208603)
52. Mackall CL, Fry TJ, Gress RE (2011) Harnessing the biology of IL-7 for therapeutic application. Nature reviews Immunology 11: 330-342.
53. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, et al. (2007) The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25: 14-18. (Pubitemid 44855247)
54. Lin W, Mathys V, Ang EL, Koh VH, Martinez Gomez JM, et al. (2012) Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism. Infection and Immunity 80: 2771-2779.
55. Jaiswal AI, Dubey C, Swain SL, Croft M (1996) Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. International immunology 8: 275-285. (Pubitemid 26049780)